Skip to content

Medical Guide

Foods are not medicines

Written by: Dr. Kerem Çağlayan Medically reviewed by: Dr. Kerem Çağlayan First published: November 14, 2022 Last updated: September 28, 2026
Short answerYes, foods promote health, and the way we eat prevents many diseases. In fact, we can treat many diseases naturally simply by changing the way we eat, making additions and eliminations. However, for example, if
Yes, foods promote health, and the way we eat prevents many diseases. In fact, we can treat many diseases naturally simply by changing the way we eat, making additions and eliminations. However, for example, if we have a hereditary cholesterol problem, paying attention to what we eat is not always the solution. Let us not forget that medications are our lifesavers when needed and that we should not give credence to the opinions of people who are not qualified in matters of health, no matter how prominent they are in the media.

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.

Related content

Drug Manufacturing in Microgravity: Why Is Varda’s $250 Million Investment Important?

Medical Guide

Drug Manufacturing in Microgravity: Why Is Varda’s $250 Million Investment Important?

Varda Space Industries received a $250 million investment to scale in-orbit pharmaceutical manufacturing. The advantages microgravity may offer to crystallization and biopharmaceutical manufacturing are becoming a genuine field of industrial research; however, its impact on routine clinical practice remains indirect.
Can 3D Culture Partially Rejuvenate Aged Limbal Niche Cells? The FOSL1 Mechanism

Medical Guide

Can 3D Culture Partially Rejuvenate Aged Limbal Niche Cells? The FOSL1 Mechanism

The study published in Aging Cell showed that 3D Matrigel culture increased stemness markers and proliferation while reducing senescence markers in aged limbal niche cells; the effect was associated with FOSL1 and mitochondrial function. Findings are at the in-vitro level.
Tulisokibart Demonstrated Strong Response in Phase 2 in Hidradenitis Suppurativa

Medical Guide

Tulisokibart Demonstrated Strong Response in Phase 2 in Hidradenitis Suppurativa

In the Phase 2 study of tulisokibart, 72% of patients in the high-dose group achieved a HiSCR50-level response at 16 weeks, while the rate was 35% with placebo; in the deeper response measure, 41% versus 15% was observed. The drug is still investigational.